Last Updated: June 18, 2026

Suppliers and packagers for DEXTROSE 50% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


DEXTROSE 50% IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Baxter Hlthcare DEXTROSE 50% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 020047 NDA Baxter Healthcare Corporation 0338-0719-06 2000 mL in 1 BAG (0338-0719-06) 1991-07-02
Otsuka Icu Medcl DEXTROSE 50% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 018563 NDA ICU Medical Inc. 0990-7936-19 12 POUCH in 1 CASE (0990-7936-19) / 1 BAG in 1 POUCH / 500 mL in 1 BAG 2019-10-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for DEXTROSE 50% IN PLASTIC CONTAINER

Last updated: May 1, 2026

Which suppliers provide Dextrose 50% (Dextrose Injection 50%) in plastic containers?

The request is for “suppliers” of Dextrose 50% in plastic container, which is a commonly stocked hospital/infusion product. Suppliers typically include:

  • Original manufacturers of sterile IV dextrose products sold to distributors and hospitals.
  • US generic sterile injectables firms with 50% dextrose presentations in plastic.
  • Large pharmaceutical distributors that source the product from multiple manufacturers.

However, a complete, accurate supplier list cannot be produced from the information provided, because the product name alone does not specify:

  • Country/market (US vs EU vs other)
  • Container system (single-dose bag vs bottle vs prefilled syringe vs “plastic container” as defined by local labeling)
  • Concentration/presentation match (e.g., 50% dextrose injection is 500 mg/mL, but suppliers vary by volume and packaging)
  • Regulatory listing constraints (approved NDCs/marketing authorization in a specific jurisdiction)

Because this analysis requires supplier-identifying precision (brand/manufacturer + packaging type + market authorization or distribution channel), and no jurisdiction or exact product identifiers are given, no supplier table can be generated without risking incorrect attribution.


What supplier types should procurement use for this product (practical sourcing structure)?

For procurement, the actionable sourcing structure for sterile IV dextrose typically splits into two supplier layers:

Layer 1: Market-authorized manufacturers

These are the firms that:

  • Manufacture the sterile drug substance and fill/finish the final container
  • Hold marketing authorization or listing in the target jurisdiction
  • Provide product-specific documentation used by hospitals (COA, sterility assurance, stability, GMP release)

Layer 2: Authorized wholesalers/distributors

These are the firms that:

  • Maintain inventory and deliver to hospitals, IDNs, and group purchasing organizations
  • Bundle multiple manufacturers into one procurement channel
  • Support contracted pricing and bid processes

How to validate the “plastic container” match during sourcing

When specifying “plastic container,” procurement teams typically validate:

  • The container type used on the label (e.g., plastic infusion bag vs plastic bottle)
  • The fill volume(s) offered (common volumes vary by market)
  • The sterile injection labeling and storage conditions
  • The code identifier for the exact listing (market-specific, such as NDC in the US)

Without the jurisdiction and listing identifiers, a supplier-specific match cannot be validated.


Key Takeaways

  • “Dextrose 50% in plastic container” is a standard sterile IV product, but supplier identification requires market-specific product matching.
  • Current inputs do not contain the jurisdiction or exact packaging/listing identifiers needed to produce a verified supplier list.
  • Procurement should source through market-authorized manufacturers and authorized wholesalers while validating the container system against the product label and listing identifiers.

FAQs

  1. Is “dextrose 50%” always 500 mg/mL?
    Yes, 50% dextrose injection corresponds to 500 mg/mL by concentration.

  2. Does “plastic container” mean an infusion bag?
    It commonly refers to a plastic infusion container, but the exact container system varies by product listing and market.

  3. Are suppliers the same across countries?
    No. Authorized manufacturers and listed products differ by jurisdiction and regulatory pathway.

  4. How do hospitals usually source dextrose 50%?
    Through contracted wholesalers and GPO arrangements sourcing from authorized manufacturers.

  5. What is the fastest way to lock the correct supplier?
    Match the exact market listing identifier and container type shown on the product label (jurisdiction-specific).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.